AI assistant
Eris Lifesciences Limited — Call Transcript 2023
Nov 1, 2023
61253_rns_2023-11-01_061cde37-7b9c-4ce2-b9cc-c70ca9841c09.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [594 x 125] intentionally omitted <==
Date: 01 November 2023
To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai- 400001 Bandra (E) Mumbai-400051 Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (“SEBI (LODR) Regulations, 2015”)
Dear Sir/Madam,
This is further to our letter dated November 01, 2023, intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30, 2023.
We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Wednesday, November 08, 2023 at 05:00 p.m., IST. The details of the said call are attached herewith and also available on Company’s website.
Thanking you.
For Eris Lifesciences Limited
Digitally signed by MILIND TALEGAONKAR MILIND DN: c=IN, postalCode=380055, st=GUJARAT, street=E42 SHRI SADAN SHAHWADI VASNAAHMEDABADOPP SWAMINARAYAN2BEHIND GB SHAH COLLEGE 380055, l=AHMEDABAD, o=Personal, title=6609, serialNumber=a508a80d3a9231304a5bf4e4182bcd5ae3ec1d08a10 TALEGAONKA 919025e2d5daa95b04426, pseudonym=660920220924180430743, 2.5.4.20=57785628ba3ced9959cf93cf3cf172cf4a41a51eb72e155a1 6f1b8fb6276b3d4, [email protected], cn=MILIND TALEGAONKAR R Date: 2023.11.01 17:37:11 +05'30'
_______ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493
Encl.: a/a
==> picture [592 x 72] intentionally omitted <==
==> picture [100 x 58] intentionally omitted <==
The Senior Management Team of
Eris Lifesciences Limited
Cordially invites you to its
Earnings Conference Call
To discuss the financial and operational performance for
Q2 & H1 FY 24
Day/Date: Wednesday, 8[th] November, 2023
Time: 5:00 PM, IST
Option 1: Express Join with Diamond Pass[ TM]
Pre-register with the below link and join without waiting for the operator:
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1289261&linkSecurityString=75558ae56
Option 2: Join through below Dial-In Numbers
Universal Dial-in Numbers
+91 22 6280 1472 / +91 22 7115 8839
| International Toll Free | International Toll Free | ||||
|---|---|---|---|---|---|
| Argentina | 0080014243444 | Germany | 0080014243444 | Singapore | 8001012045 |
| Australia | 1800053698 | HongKong | 800964448 | South Korea | 00180014243444 |
| Belgium | 0080014243444 | Italy | 0080014243444 | Sweden | 0080014243444 |
| Canada | 01180014243444 | Japan | 00531161110 | Thailand | 00180014243444 |
| China | 4008428405 | Netherlands | 08000229808 | UK | 08081011573 |
| France | 0800914745 | Poland | 008001124248 | USA | 18667462133 |
We look forward to your participation RSVP: Kruti Raval: [email protected]